Skip to content

Ganglioside GM3 (Sulfatide) in Serum

Published: August 9, 2026Updated: August 16, 2026

This test measures the level of a specific type of ganglioside called GM3 sulfatide in your blood serum. GM3 sulfatide is a complex carbohydrate-lipid molecule that can be involved in certain neurological and metabolic conditions.

Quick summary

["Understanding your GM3 sulfatide level may help assess rare genetic or metabolic disorders."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
44753-2
Short code
Sulfatide IgM Ser Ql
Synonyms
Sulfatide IgM Ser Ql
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms or a family history suggestive of metabolic disorders, such as GM1 gangliosidosis or other lysosomal storage diseases. It may also be part of a broader diagnostic workup for neurological issues or genetic testing.

What to Expect Before the Test

No special preparation is typically required. You may have a blood draw, similar to other routine blood tests. If you are on certain medications or have specific health conditions, let your provider know beforehand.

What the Results Mean

Results are not standardized across labs, so interpretation depends on clinical context and comparison to your baseline or known reference ranges for this specific test. Elevated levels may indicate certain metabolic disorders, while normal levels do not definitively rule out conditions.

Common Conditions Monitored

This test is often used in the context of diagnosing or monitoring lysosomal storage disorders, such as GM1 gangliosidosis, or other rare genetic conditions affecting lipid metabolism.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical significance: Elevated levels of GM3 sulfatide in serum can be associated with lysosomal storage diseases, where certain enzymes are deficient, leading to the buildup of specific substances like GM3. Your provider will use these results alongside clinical findings, family history, and other tests to guide diagnosis and treatment planning.

Short name

GM3 Sulfatide Serum

Frequently asked questions

What does a high GM3 sulfatide level indicate?
A high level may suggest a lysosomal storage disorder or another metabolic condition affecting lipid metabolism. Your healthcare provider will review these results with your symptoms and other test results to determine the next steps.
Is this test painful?
The test involves a small needle insertion for blood draw, which may cause mild discomfort. Most people experience it as a brief pinch. If you have a fear of needles, let your provider know so they can offer strategies to help.
How often will I need this test?
The frequency depends on your medical condition and treatment plan. Your healthcare provider will discuss this with you during your appointment or after receiving your results.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy